Copyright Reports & Markets. All rights reserved.

Global Daclatasvir Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Daclatasvir Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 30mg Tables
      • 1.2.2 60mg Tables
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hepatitis C Virus (HCV) Genotype 1
      • 1.3.2 Hepatitis C Virus (HCV) Genotype 3
      • 1.3.3 Hepatitis C Virus (HCV) Genotype 4
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Bristol-Myers Squibb
      • 2.1.1 Business Overview
      • 2.1.2 Daclatasvir Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Bristol-Myers Squibb Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Natco Pharma
      • 2.2.1 Business Overview
      • 2.2.2 Daclatasvir Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Natco Pharma Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Zydus Cadila
      • 2.3.1 Business Overview
      • 2.3.2 Daclatasvir Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Zydus Cadila Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Hetero Drugs
      • 2.4.1 Business Overview
      • 2.4.2 Daclatasvir Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Hetero Drugs Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Dr Reddy's Laboratories
      • 2.5.1 Business Overview
      • 2.5.2 Daclatasvir Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Dr Reddy's Laboratories Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Cipla
      • 2.6.1 Business Overview
      • 2.6.2 Daclatasvir Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Cipla Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Mylan
      • 2.7.1 Business Overview
      • 2.7.2 Daclatasvir Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Mylan Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Abbott
      • 2.8.1 Business Overview
      • 2.8.2 Daclatasvir Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Abbott Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Emcure Pharmaceuticals
      • 2.9.1 Business Overview
      • 2.9.2 Daclatasvir Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Emcure Pharmaceuticals Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Torrent Pharmaceuticals
      • 2.10.1 Business Overview
      • 2.10.2 Daclatasvir Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Torrent Pharmaceuticals Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Biocon
      • 2.11.1 Business Overview
      • 2.11.2 Daclatasvir Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Biocon Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Daclatasvir Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Daclatasvir Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Daclatasvir Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Daclatasvir Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Daclatasvir Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Daclatasvir Market Analysis by Regions

    • 4.1 Global Daclatasvir Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Daclatasvir Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Daclatasvir Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Daclatasvir Sales and Growth Rate (2014-2019)
    • 4.3 Europe Daclatasvir Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Daclatasvir Sales and Growth Rate (2014-2019)
    • 4.5 South America Daclatasvir Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Daclatasvir Sales and Growth Rate (2014-2019)

    5 North America Daclatasvir by Country

    • 5.1 North America Daclatasvir Sales, Revenue and Market Share by Country
      • 5.1.1 North America Daclatasvir Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Daclatasvir Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Daclatasvir Sales and Growth Rate (2014-2019)
    • 5.3 Canada Daclatasvir Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Daclatasvir Sales and Growth Rate (2014-2019)

    6 Europe Daclatasvir by Country

    • 6.1 Europe Daclatasvir Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Daclatasvir Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Daclatasvir Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Daclatasvir Sales and Growth Rate (2014-2019)
    • 6.3 UK Daclatasvir Sales and Growth Rate (2014-2019)
    • 6.4 France Daclatasvir Sales and Growth Rate (2014-2019)
    • 6.5 Russia Daclatasvir Sales and Growth Rate (2014-2019)
    • 6.6 Italy Daclatasvir Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Daclatasvir by Country

    • 7.1 Asia-Pacific Daclatasvir Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Daclatasvir Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Daclatasvir Revenue and Market Share by Country (2014-2019)
    • 7.2 China Daclatasvir Sales and Growth Rate (2014-2019)
    • 7.3 Japan Daclatasvir Sales and Growth Rate (2014-2019)
    • 7.4 Korea Daclatasvir Sales and Growth Rate (2014-2019)
    • 7.5 India Daclatasvir Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Daclatasvir Sales and Growth Rate (2014-2019)

    8 South America Daclatasvir by Country

    • 8.1 South America Daclatasvir Sales, Revenue and Market Share by Country
      • 8.1.1 South America Daclatasvir Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Daclatasvir Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Daclatasvir Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Daclatasvir Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Daclatasvir Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Daclatasvir by Countries

    • 9.1 Middle East and Africa Daclatasvir Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Daclatasvir Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Daclatasvir Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Daclatasvir Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Daclatasvir Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Daclatasvir Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Daclatasvir Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Daclatasvir Sales and Growth Rate (2014-2019)

    10 Global Daclatasvir Market Segment by Type

    • 10.1 Global Daclatasvir Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Daclatasvir Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Daclatasvir Revenue and Market Share by Type (2014-2019)
    • 10.2 30mg Tables Sales Growth and Price
      • 10.2.1 Global 30mg Tables Sales Growth (2014-2019)
      • 10.2.2 Global 30mg Tables Price (2014-2019)
    • 10.3 60mg Tables Sales Growth and Price
      • 10.3.1 Global 60mg Tables Sales Growth (2014-2019)
      • 10.3.2 Global 60mg Tables Price (2014-2019)

    11 Global Daclatasvir Market Segment by Application

    • 11.1 Global Daclatasvir Sales Market Share by Application (2014-2019)
    • 11.2 Hepatitis C Virus (HCV) Genotype 1 Sales Growth (2014-2019)
    • 11.3 Hepatitis C Virus (HCV) Genotype 3 Sales Growth (2014-2019)
    • 11.4 Hepatitis C Virus (HCV) Genotype 4 Sales Growth (2014-2019)

    12 Daclatasvir Market Forecast (2019-2024)

    • 12.1 Global Daclatasvir Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Daclatasvir Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Daclatasvir Market Forecast (2019-2024)
      • 12.2.2 Europe Daclatasvir Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Daclatasvir Market Forecast (2019-2024)
      • 12.2.4 South America Daclatasvir Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Daclatasvir Market Forecast (2019-2024)
    • 12.3 Daclatasvir Market Forecast by Type (2019-2024)
      • 12.3.1 Global Daclatasvir Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Daclatasvir Market Share Forecast by Type (2019-2024)
    • 12.4 Daclatasvir Market Forecast by Application (2019-2024)
      • 12.4.1 Global Daclatasvir Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Daclatasvir Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Scope of the Report:
      The worldwide market for Daclatasvir is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Daclatasvir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Bristol-Myers Squibb
      Natco Pharma
      Zydus Cadila
      Hetero Drugs
      Dr Reddy's Laboratories
      Cipla
      Mylan
      Abbott
      Emcure Pharmaceuticals
      Torrent Pharmaceuticals
      Biocon

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      30mg Tables
      60mg Tables

      Market Segment by Applications, can be divided into
      Hepatitis C Virus (HCV) Genotype 1
      Hepatitis C Virus (HCV) Genotype 3
      Hepatitis C Virus (HCV) Genotype 4

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Daclatasvir product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Daclatasvir, with price, sales, revenue and global market share of Daclatasvir in 2017 and 2018.
      Chapter 3, the Daclatasvir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Daclatasvir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Daclatasvir market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Daclatasvir sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now